Patents by Inventor Thomas G. Heffner

Thomas G. Heffner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5073561
    Abstract: Certain N-substituted 1-(1,2,3,6-tetrahydro-3-pyridinyl)oximes and N-substituted 1-(1,2,3,6-tetrahydro-4-pyridinyl)oximes are useful as sigma binding agents for the treatment of depression, psychoses and/or inflammatory diseases.
    Type: Grant
    Filed: March 5, 1990
    Date of Patent: December 17, 1991
    Assignee: Warner-Lambert Company
    Inventors: Linda L. Coughenour, Robert E. Davis, David A. Downs, Thomas G. Heffner, Leonard T. Meltzer, Walter H. Moos, David W. Moreland, Haile Tecle
  • Patent number: 4929734
    Abstract: Certain N-substituted 1-(1,2,3,6-tetrahydro-3-pyridinyl)oximes and N-substituted 1-(1,2,3,6-tetrahydro-4-pyridinyl)oximes are useful as sigma binding agents for the treatment of depression, psychoses and/or inflammatory diseases.
    Type: Grant
    Filed: October 18, 1988
    Date of Patent: May 29, 1990
    Assignee: Warner-Lambert Company
    Inventors: Linda L. Coughenour, Robert E. Davis, David A. Downs, Thomas G. Heffner, Leonard T. Meltzer, Walter H. Moos, David W. Moreland, Haile Tecle
  • Patent number: 4701456
    Abstract: Aminoalkyoxybenzopyranones of the formula ##STR1## wherein R.sub.1 is of the formula ##STR2## are described as well as methods of preparation, pharmaceutical compositions and methods for treating anxiety and psychoses such as schizophrenia therewith.
    Type: Grant
    Filed: June 18, 1985
    Date of Patent: October 20, 1987
    Assignee: Warner-Lambert Company
    Inventors: Horace A. Dewald, Lawrence D. Wise, Thomas G. Heffner
  • Patent number: 4582823
    Abstract: A method for treating schizophrenia without precipitating neurological side effects such as extrapyramidal syndrome and tardive dyskinesia by administering prior to or concomitantly with haloperidol a diphenylalkyladenosine or diphenylalkyl-2-amino-adenosine is described as well as pharmaceutical compositions therefor.
    Type: Grant
    Filed: August 15, 1984
    Date of Patent: April 15, 1986
    Assignee: Warner-Lambert Company
    Inventors: Thomas G. Heffner, Stephen E. Harrigan, Jerry A. Weisbach